October 28, 2026 · Circulation. Arrhythmia and electrophysiology · DOI: 10.1161/CIRCEP.126.015246

Cardiac Electrophysiological Impact of Sodium Glucose Cotransporter 2 Inhibitors: A Comprehensive Review.

Listen to this summary

This review asks whether SGLT2 inhibitors, beyond their glycemic and heart failure benefits, meaningfully affect cardiac autonomic function, arrhythmia risk, and related microRNA signaling. The authors synthesize clinical trials, meta-analyses, and preclinical studies, finding evidence of sympathoinhibition, modest reductions in atrial fibrillation/flutter and possibly sudden cardiac death, and anti-arrhythmic mechanisms such as NHE and late sodium current inhibition. They also report that SGLT2 inhibitors modulate microRNAs (e.g., miR-21, miR-29, miR-30, miR-34a, miR-92) that may underlie these effects, but they conclude that dedicated trials are needed to establish causality and dose-dependence.

Vishnu Ashok, Ven Gee Lim, S M Zubair Rahim, Hardip Sandhu, Michael S Dodd, G Andre Ng, Derek Renshaw, Helen Maddock, Faizel Osman

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play